September 18, 2008 – The Medical Imaging & Technology Alliance (MITA) said today that the results of the National CT Colonography Trial, published in this week’s New England Journal of Medicine, demonstrate the vast benefits of virtual colonoscopy (VC) as an important tool for colon cancer screening.

“Access to proper diagnostic equipment such as virtual colonoscopy is imperative to the detection and treatment of colon cancer,” said Maureen Zilly, director, Government Relations, MITA. “MITA applauds the work of Dr. Johnson and his team, whose definitive study reminds us of how critical it is that patients and their doctors have access to life-saving, noninvasive medical imaging technology, enabling them to benefit from the right scan at the right time in fighting serious disease such as colon cancer."

The study, which was led by C. Daniel Johnson, M.D., of the Mayo Clinic and funded by the National Institutes of Health (NIH), analyzed data from 2,531 asymptomatic participants in 15 centers across the country, making it the largest and most comprehensive VC trial to date.

The purpose of the study was to measure VC sensitivity for detecting adenoma growths one centimeter or larger in diameter, with standard colonoscopy serving as a reference point. The results were impressive, with VC demonstrating a 90 percent per-patient sensitivity rate – comparable to that of standard optical colonoscopy. In addition, because only 8.3 percent of patients would have required an additional, same-day optical colonoscopy for removal of polyps 6mm or larger, VC was shown to be highly effective.

“Colon cancer is the second leading cause of cancer-related deaths in America, yet recent statistics show that only a third of Americans eligible for screening ever get tested,” said Tim Turnham, CEO of the Colon Cancer Alliance. "We hope this research, which shows virtual colonoscopy screening to be equally as effective as other traditional, more invasive procedures, will encourage more individuals to go out and get screened.”

For more information: www.medicalimaging.org


Related Content

News | ACR

February 6, 2024 — An update to the CT Colonography Reporting and Data System (C-RADS) has been published Jan. 30 in the ...

Time February 06, 2024
arrow
News | Colonoscopy Systems

A team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies as a disposable version inches closer to widespread availability.

Time August 26, 2019
arrow
News | Colonoscopy Systems

A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer (CRC) in younger adults, adding to evidence that the rise in early onset CRC is not solely a result of more detection. The study is published early online in the Journal of Medical Screening.

Time August 06, 2019
arrow
News | Colonoscopy Systems

Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through detection of precancerous polyps, following Institutional Review Board (IRB) approval and full Investigational Device Exemption (IDE) application approval by the U.S. Food and Drug Administration (FDA). The first patients have ingested C-Scan, a preparation-free capsule, at the New York University School of Medicine.

Time April 15, 2019
arrow
News | Colonoscopy Systems

https://www.congress.gov/bill/115th-congress/house-bill/1298?q=%7B%22se… cancer care advocacy groups and medical societies are calling on Congress to pass the CT Colonography Screening for Colorectal Cancer Act (S.3465/HR 1298). The bipartisan bill introduced in the U.S. Senate September 19 would provide Medicare coverage for screening computed tomography colonography (CTC), commonly known as virtual colonoscopy.

Time September 27, 2018
arrow
News | Colonoscopy Systems

Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an ingestible, capsule-based device for preparation-free colorectal cancer (CRC) screening. The company said data from the multicenter clinical investigation showed promising results for detecting patients with polyps in an un-prepped colon.

Time September 04, 2018
arrow
News | Colonoscopy Systems

An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk. The recommendation is based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.

Time May 30, 2018
arrow
News | Colonoscopy Systems

February 8, 2018 – The U.S. Food and Drug Administration (FDA) announced on February 7, 2018, that Pentax Medical’s ...

Time February 08, 2018
arrow
News | Colonoscopy Systems

August 31, 2017 — A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper ...

Time August 31, 2017
arrow
News | Colonoscopy Systems

People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are almost 50 percent more likely to get screened than those whose policies don’t cover the procedure, according to a new study appearing online in the journal Radiology.

Time July 12, 2017
arrow
Subscribe Now